Sonic Incytes Announces Velacur™️ Use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial
Sonic Incytes Medical Corp. is pleased to announce the inclusion of VelacurTM — the first handheld 3D liver health assessment tool—in a subset of Madrigal Pharmaceutical’s MAESTRO NAFLD-1 Phase 3… Read More


